Injected drug, lecanemab, slowed the progress of the brain-wasting disease by 27 percent compared to a placebo, meeting the study's main goal, say drugmakers Eisai and Biogen.
While palpable, relief over a US-Mexico trade deal was dimmed by concerns that the China-US trade war will drag on for some time.
Subscribe to our Youtube channel for all latest in-depth, on the ground reporting from around the world.
Copyright © 2023 TRT World.
Like
Follow